PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.02%
Positive revenue growth while 3088.T is negative. John Neff might see a notable competitive edge here.
7.85%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
14.12%
Positive EBIT growth while 3088.T is negative. John Neff might see a substantial edge in operational management.
30.87%
Positive operating income growth while 3088.T is negative. John Neff might view this as a competitive edge in operations.
8.00%
Positive net income growth while 3088.T is negative. John Neff might see a big relative performance advantage.
8.01%
Positive EPS growth while 3088.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
8.01%
Positive diluted EPS growth while 3088.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3088.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3088.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.61%
10Y revenue/share CAGR under 50% of 3088.T's 15.44%. Michael Burry would suspect a lasting competitive disadvantage.
1.61%
5Y revenue/share CAGR under 50% of 3088.T's 15.44%. Michael Burry would suspect a significant competitive gap or product weakness.
-23.57%
Negative 3Y CAGR while 3088.T stands at 5.82%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
0.22%
Positive 10Y CAGR while 3088.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
0.22%
Positive 5Y CAGR while 3088.T is negative. John Neff might view this as a strong mid-term relative advantage.
-39.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.39%
Negative 3Y equity/share growth while 3088.T is at 39.03%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-99.58%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.78%
Inventory is declining while 3088.T stands at 5.66%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
6.99%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.08%
Positive BV/share change while 3088.T is negative. John Neff sees a clear edge over a competitor losing equity.
10.80%
We have some new debt while 3088.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
63.10%
SG&A growth well above 3088.T's 16.18%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.